TARANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Protara Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$2.33+0.01 (+0.43%)
Close on Oct 19, 2026
- Market cap
- $142.15M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Protara Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2026 | Jun 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2026 | Jun 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 13, 2026 | May 13, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2026 | Apr 28, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Mar 30, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 10, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2026 | Mar 10, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 23, 2026 | Feb 24, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 15, 2025 | Dec 15, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 4, 2025 | Dec 8, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 3, 2025 | Dec 3, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 19, 2025 | Nov 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2025 | Jun 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 26, 2025 | Apr 28, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 11, 2025 | Apr 25, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 5, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2025 | Mar 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2024 | Dec 11, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 5, 2024 | Dec 5, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 7, 2024 | Jun 10, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 2, 2024 | SEC EDGAR |
| Current report | 8-K | May 2, 2024 | May 2, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 7, 2024 | Apr 26, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 5, 2024 | Apr 5, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2024 | Mar 18, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 13, 2024 | SEC EDGAR |